STAT+: New rule would force PBMs to disclose drug rebates...

What’s Happening

Let’s talk about The proposal would mark a significant change for the secretive PBM industry, which often shields crucial data from its clients.

The Readout The Readout STAT Plus: AstraZeneca looks to China for obesity drug candidates By Meghana Keshavan Business Business STAT Plus: Trump’s latest deal: $600 million of tech company discounts to help implement Medicaid work requirements By Tara Bannow Politics Politics STAT Plus: Senators raise concerns about TrumpRx in letter to HHS watchdog By Katie Palmer The Readout The Readout STAT Plus: Lilly, Repertoire strike $2 billion autoimmune alliance By Meghana Keshavan Special Report Special Report STAT Plus: How Opvee, Indivior’s powerful overdose antidote, went bust By Lev Facher STAT Plus: AI biotech founded by ex-Google CEO Eric Schmidt is raising $150 million By Brittany Trang STAT Plus: How Opvee, Indivior’s powerful overdose antidote, went bust By Lev Facher STAT Plus: FDA’s new ‘plausible mechanism pathway’ for personalized gene editing raises concerns By Jason Mast STAT Plus: Endometriosis often takes years to diagnose. (and honestly, same)

Why This Matters

This is the kind of health news that affects everyday decisions.

Medical professionals are taking note of this development.

The Bottom Line

This story is still developing, and we’ll keep you updated as more info drops.

What do you think about all this?